ATHEROGENICS INC 4
4 · ATHEROGENICS INC · Filed Jun 15, 2006
Insider Transaction Report
Form 4
ATHEROGENICS INCAGIX
SCOTT ROBERT A
Sr VP Clinical Dev & RA
Transactions
- Exercise/Conversion
Incentive stock option (right to buy)
2006-06-13−14,204→ 23,296 totalExercise: $7.04Exp: 2012-08-30→ Common stock (14,204 underlying) - Exercise/Conversion
Common stock
2006-06-13$7.04/sh+14,204$99,996→ 14,204 total
Footnotes (1)
- [F1]25% of these options vested on 08/30/2003, the first anniversary of the date of grant. Following that date, the remaining options vest at a rate of 2%-3% per month over the next 36 months.